Document is current
Any future updates will be listed below
-
Authors
Wang, Xuejun
Lin, Qinghong
Tian, Li
Li, Xiaoying
Fukuyama, Teruko
Ten, Weijung
Kong, Xiehe
Yang, Yanting
Ma, Xiaopeng
Zhou, Xingtao https://orcid.org/0000-0002-3465-1579
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82305379, 82371096)
China National Postdoctoral Program for Innovative Talents (BX20230095)
China Postdoctoral Science Foundation (2023M740740)
National Key Research and Development Program of China (2023YFA0915000 (04))
Project of Shanghai Science and Technology (20410710100)
Project of Shanghai Xuhui District Science and Technology (XHLHGG202104)
Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care (20DZ2255000)
the Construction of a 3D digital intelligent prevention and control platform for the whole life cycle of highly myopic patients in the Yangtze River Delta (21002411600)
- License Information
-
More Information
Article History
Received: 24 May 2024
Accepted: 2 January 2025
First Online: 2 February 2025
Declarations
:
: The animal procedures in the present study have been approved by the Laboratory Animal Ethics Committee of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine (No. YYLAC-2022-158-1). Retinas were obtained from the eyeballs of normal adult, myopic adult and highly myopic adult donors with the approval of the Ethics Committee of Eye & ENT Hospital, Fudan University (No. 2023114) and followed the guidelines of the Declaration of Helsinki. Informed consent was obtained from all participants.
: Not applicable.
: The authors declare that there are no conflicts of interest.
